Christopher O. McGovern

ORCID: 0009-0002-2058-3410

NeuroscienceMedicineEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Aptamer-Targeted Calcium Phosphosilicate Nanoparticles for Effective Imaging of Pancreatic and Prostate Cancer”.

Aptamer-Targeted Calcium Phosphosilicate Nanoparticles for Effective Imaging of Pancreatic and Prostate Cancer

International Journal of Nanomedicine(2021)10.2147/ijn.s295740

N/A

0DataRank · unranked

20 citations

Christopher O. McGovern, Samuel S. Linton, Zachary Wilczynski, James H. Adair, Gail L. Matters +1 more

Preferential uptake of antibody targeted calcium phosphosilicate nanoparticles by metastatic triple negative breast cancer cells in co-cultures of human metastatic breast cancer cells plus bone osteoblasts

Nanomedicine Nanotechnology Biology and Medicine(2021)10.1016/j.nano.2021.102383

N/A

0DataRank · unranked

9 citations

Christopher Gigliotti, Bernadette M. Adair, Jenna Snyder, Nicholas T. Gigliotti, Welley Siu Loc +10 more

CCK Receptor Inhibition Reduces Pancreatic Tumor Fibrosis and Promotes Nanoparticle Delivery

Biomedicines(2024)10.3390/biomedicines12051024

N/A

0DataRank · unranked

1 citations

Michael Armold, Christopher O. McGovern, John F. Harms, Matthew C. Darok, Christopher Gigliotti +6 more